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Abstract
Autoimmune thyroid diseases (AITD) are the most common group of autoimmune diseases, associated with lymphocyte infiltration and the production of thyroid autoantibodies, like thyroid peroxidase antibodies (TPOAb), in the thyroid gland.
Immunoglobulins (Igs) and cell-surface receptors are glycoproteins with distinctive glycosylation patterns that play a structural role in maintaining and modulating their functions. We investigated associations of total circulating IgG and peripheral blood mononuclear cells (PBMCs) glycosylation with AITD and the influence of genetic background. The study revealed an inverse association of IgG core fucosylation with TPOAb and PBMCs antennary α1,2 fucosylation with AITD, but no shared genetic variance between AITD and glycosylation. These data suggest that the decreased level of IgG core fucosylation is a risk factor for AITD that promotes antibodydependent cell-mediated cytotoxicity (ADCC) associated with TPOAb levels.
Introduction
Autoimmune thyroid diseases (AITD) are a class of chronic, organ-specific autoimmune disorders that disturb the function of the thyroid gland. They affect close to 5% of the European population (with a gender disparity) and so, represent the most common group of autoimmune diseases 1 . AITD encompass a spectrum of conditions including Hashimoto's thyroiditis (HT) and Graves' disease (GD). One of the features of AITD is the production of autoantibodies against components of thyroid cells that are also detected in the bloodstream.
The autoantibodies are produced against the three core thyroid proteins: thyroid peroxidase (TPO), thyroglobulin (Tg), and the thyroid-stimulating hormone receptor (TSH-R). Except for antibodies against TSH receptors (TSAb), which are known to stimulate the production of thyroid hormones by binding TSH receptors in GD 2 , little is known about the role of two other thyroid autoantibodies, thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TgAb). Circulating TPOAb is the most common and diagnostically useful marker of AITD, detectable in the serum of most HT (95%) and GD (85%) patients 3 . In recent years, using TPOAb as a marker has been challenged since it appears in approximately 10% of apparently healthy individuals 4 . Even though autoantibodies are often a hallmark of autoimmune disorders, they can appear years before the first symptoms 5 , which poses the question about their causative role. Some evidence exists that autoantibodies can trigger autoimmunity, and IgG isotype seems to be connected with the development of autoimmune diseases potentially through regulation of IgG effector functions by alternative glycosylation 5 . However, it is yet to be determined if anti-thyroid antibodies cause AITD, or whether additional control mechanisms, such as post-translational modifications, are required to trigger the disease onset.
The most abundant and diverse form of post-translational modification is glycosylation, the attachment of sugar moieties to proteins, and various glycans are involved in virtually all physiological processes 6 . Glycans attached to Immunoglobulin G (IgG) are indispensable for its effector function and control of inflammation [7] [8] [9] [10] . There are two glycosylation sites within the fragment crystallizable (Fc) of IgG that affect the 6 molecule's 3D-conformation and affinity for binding to Fcɣ-receptors (FcɣRs) on a range of immune cells 6, 11, 12 . Additional N-glycosylation sites are present in approximately 20% of IgG fragment antigen binding (Fab) and play a role in immunity, such as the affinity of epitope-binding site [13] [14] [15] [16] . Previous analysis of IgG glycosylation with other autoimmune diseases showed a reduction of IgG galactosylation and sialylation, which trigger inflammatory response [17] [18] [19] [20] . In relation to AITD, two small studies (62 and 146 patients respectively) looked at the TgAb glycosylation and reported differences between AITD, papillary thyroid cancers (PTC), and controls 21, 22 .
First, TgAb IgG from HT patients showed higher levels of core fucose than the control group, as well as of terminal sialic acid and mannose 21 . On the other hand, it was observed that among HT, GD, and PTC groups, HT patients had significantly lower core fucose content on TgAb than the other two groups 22 . Furthermore, since recent genome-wide association studies (GWAS) identified novel loci associated with IgG glycosylation, which were known to be strongly associated with autoimmune conditions 23, 24 and the heritability of AITD is estimated to 55-75% [25] [26] [27] , the next logical Table 2) , and the amount of glycans in each peak was expressed as a percentage of the total integrated area. Furthermore, we excluded glycan peak GP3 due to the co-elution with the contaminant and combined GP20 and GP21 to get 22 directly measured N-glycan traits ( Fig. 1c,d ; Supplementary Table 2 ). As many of these structures share the same features (terminal galactose, terminal sialic acid, core-fucose, bisecting N-acetylglucosamine (GlcNAc)), we calculated 53 additional derived traits that average these features across multiple glycans ( Fig. 1c,d; Supplementary Table 2 ). Latter structural features were found to be more closely related to individual enzymatic activities in different cellular compartments 29 and underlying genetic polymorphisms 23 than the 24 original glycan peaks. As all these structural features partially correlated (Fig. 1b) , we estimated only 20 independent glycan traits 23 in our data using the Equation (5) (Fig. 1c, d ). Box plot with whiskers represents five summary statistics (the median, the first and third quartiles for two hinges and 1.5 times interquantile range from the hinges for two whiskers). Outliers are labeled by the red dot adjacent to the black dot of the measurement. Image created with R package called ggplot2.
d) PBMC protein extracts were resolved on 10% SDS-PAGE gels in reducing conditions. After electrophoresis, the proteins were electrotransferred to a PVDF membrane and stained with the UEA I lectin (ncase=9 and ncontrol=10; Supplementary Table 5 HT is associated with the decreased level of IgG core fucose and the PBMC antennary remain decreased (Fig. 2a) . In contrast, only one of the 17 IgG N-glycan traits that were significant in the discovery cohort (TPOAb level and AITD status;
Supplementary Table 3 Table 1 ) was also examined in three batches by lectin blotting using
Aleuria aurantia lectin (AAL), specific for α1,6-linked core fucose. We observed a consistently decreased level of IgG core fucosylation associated with HT status using AAL in the three batches, but none were significant with sample size tested ( Table 1 ) was examined by lectin blotting using seven lectins with different sugar specificity: AAL, Galanthus nivalis lectin (GNL),
Mackia amurensis lectin (MAL-II), Phaseolus vulgaris erythroagglutinin (PHA-E),

Phaseolus vulgaris leucoagglutinin (PHA-L), Sambucus nigra agglutinin (SNA), and
Ulex europaeus agglutinin (UEA I). Lectin blotting with UEA l identified a significant reduction of antennary α1,2 fucose in patients with HT ( Fig. 2d) whereas blotting with AAL, which preferentially binds core fucose (α1,6), as well as all other lectin blotting assays, showed no difference in the content of particular glycan species between HT and control group (Supplementary Fig. 1 , Supplementary Fig. 2 ). To summarize, we found six significant glycans in the UK HT discovery cohort that were also associated with the TPOAb level (one was replicated in the Polish cohort) and a decrease of PBMC antennary α1,2 fucose associated with HT.
AITD and IgG N-glycan traits are highly heritable, but no shared genetic effect between them could be determined Table 2 ). Given that the heritability for AITD and TPOAb-positivity predicts only a dominance genetic variance as a fraction of genetic variance, and the heritability of IgG N-glycan traits was estimated to be composed with mostly additive genetic variance, the portion of shared genetic variances between AITD and IgG N-glycan traits using a bivariate heritability analysis 34 could not be determined. Lead SNPs associated with IgG glycan FA2G1S1 and TPOAb-positivity fall in the same high LD nearby HCP5 gene
Next, we investigated whether specific genetic variants determined by previous
GWASs could explain some genetic components potentially shared between AITD status and IgG N-glycan traits. We compared the results from internal GWASs of IgG N-glycan traits in the TwinsUK cohort (around 4,500 individuals) 24 and previous
GWASs of IgG N-glycan traits 23 with results from the GWAS catalog for thyroid diseases and functions including GD, TPOAb-positivity, hypothyroidism, hyperthyroidism, levels of thyroid hormones 37 (Supplementary Table 7 (Fig. 3) . Moreover, we found that the lead SNP of IGP14 and IGP54 an eQTL for C4A (thyroid, P-value=2.2x10 -14 ; whole blood P-value=1.5x10 -7 ), CYP21A1P (thyroid, P-value=4.7x10 -12 ; whole blood P-value=2.0x10 -9 ), HLA-C (thyroid, P-value=1.9x10-6), HCP5 (thyroid, P-value=1.1x10 -9 ; whole blood, p=1.2x10 -9 ), and CYP21A2 (whole blood, P-value=7.1x10 -8 ), whereas rs3094228 is associated with expression of C4A (thyroid, P-value=3.4x10 -13 ; whole blood P-value=1.07x10 -7 ), CYP21A1P (thyroid, P-value=1.1x10 -9 ; whole blood P-value=3. However, when we reduced the case group from Croatia to 83 individuals with very high TPOAb (>100 IU/ml in Roche assay, the same criteria to define AITD status in the TwinsUK cohort), the associations for the six replicated IgG N-glycan traits became more significant while the beta values remained similar to the preceding analysis (Supplementary Table 3 -Sheet 4) . Using lectin blotting in the Polish cohort, we validated the reduction of core-fucosylated IgG in HT patients, but due to the lack of data on TPOAb levels for HT patients (i.e. analyzed in the same blood collected for
IgG glycosylation analysis), we could not confirm the association with TPOAb level rather than AITD status. Overall, our results suggest that the decreased fraction of core-fucosylated IgG could be more related to the level of TPOAb than the status of AITD.
Several studies showed that 95 % of IgG N-glycan structures in a healthy individual have core fucose and it acts as a "safety switch", attenuating potentially harmful ADCC [44] [45] [46] [47] [48] . Using FUT8 knockout Chinese hamsters, one previous study produced defucosylated CD20 antibodies and showed that afucosylated antibodies have a much higher affinity for FcγRIIIa (CD16a) -an immunoglobulin receptor distributed on natural killer (NK) cells, macrophages, and γδ T cells. They enhanced ADCC over 100-fold more than fucosylated CD20 antibodies 49 . Production of antibodies without the core fucose has recently revolutionized antibody therapies, by providing substantially enhanced ADCC 50, 51 . Thus, the deficiency of IgG core fucose observed in the people with AITD and TPOAb-positivity in our data and the activities of IgG core fucose on the immune system previously identified, suggest an increase of ADCC in TPOAb positive individuals.
Interestingly, ADCC was previously reported in AITD without restriction to subgroups of patients, however, more patients with HT than with GD presented ADCC activities 52, 53 . Although no strong correlation of TPOAb level (total IgG or IgG subclasses) measured by enzyme-linked immunosorbent assay (ELISA) with ADCC activity could be found in previous studies, and other thyroid antigens besides TPO could be involved in ADCC, TPO was described as the primary antigen involved in the thyroid ADCC [52] [53] [54] [55] . Deglycosylation of TPOAb was shown to reduce the binding to
FcγRs and thus inhibit the apoptosis of thyroid cancer cells via complement-dependent cytotoxicity (CDC) and cytotoxicity via ADCC 54 . Although IgG glycosylation studied in the present paper is of total and not antigen-specific IgG, we found a relationship between TPOAb level and IgG core fucose, and we suggest that the depletion of core fucose observed in TPOAb circulating in blood could enhance their cytotoxicity activities on thyrocytes through ADCC (Fig. 5) .
Furthermore, taking advantage of the twin study design of the discovery cohort, we tested shared genetic and environmental effects between different significant glycan features found to be associated with TPOAb positivity and AITD in this study.
Surprisingly, although previous GWASs on IgG N-glycan traits showed several SNPs also associated with autoimmune diseases 23, 56 , no shared genetic variance or lead Based on the findings of GWASs performed on the IgG N-glycan traits 23 , we also showed an enrichment of the afucosylated IgG N-glycan traits that are associated with FUT8 and IKZF1 genes. Both genes were considered leading players in the core fucosylation of IgGs, although the mechanism of IKZF1 gene in the fucosylation is still unclear 23 . The IKZF1 gene encodes a transcription factor belonging to the family of 31, 32, 37 . However, even though these two fucosylation enzymes were found to be associated with the significant Nglycan structures from the present study, we could not find a direct association of the TPOAb and 0.7 mg/ml for TgAb) [65] [66] [67] . Knowing that normal IgG concentration range is 5.1-15.8 mg/ml, in extreme cases, thyroid autoantibodies could represent up to 50% of total IgGs, and their presence in the blood can also increase the serum levels of total IgGs 68, 69 . Thus, the secretion of thyroid antibodies can alter the concentration of total IgG in AITD.
If the modification of IgG glycosylation observed in the current study is the consequence of increased TPOAb concentration in total IgGs, the hypothesis that the depletion of IgG core fucose is a biomarker of TPOAb and its activity, and thereby a risk factor of harmful ADCC in the thyroid cells triggered by TPOAb (Fig. 5) prospective longitudinal studies that look at these traits before and after the diagnostic of AITD, as well as Mendelian randomization 70, 71 in large independent cohorts would be required.
Conclusion
This study identified for the first time an association of decreased level of IgG corefucosylation and PBMC antennary α1,2 fucosylation with TPOAb level and AITD. This is also the first time that a decrease of fucosylation on IgG and PBMC is associated with one autoimmune disease and one of its biomarkers. Our findings could not be explained by common genetic background or general dysregulation of gene expression in the whole blood. However, drawing from the knowledge generated in a large number of previous studies, we could speculate that this reduction of IgG core fucose could be a consequence of tissue-specific aberrant gene expression. Moreover, we hypothesized that the decreased IgG core fucosylation could be a novel risk factor for potentially harmful ADCC in the thyroid gland, associated with TPOAb and AITD.
Further studies of the glycosylation of thyroid autoantibodies and their interactions with other immune features (e.g., immune cell-types, secreted proteins) and thyroid cells may be helpful to elucidate the potential role of autoantibodies and their glycosylation patterns in the pathogenesis and the treatment of thyroid diseases.
